Home »
News Par Views News
News Par Views
Concord Biotech IPO: Listing at 21.5% Premium & Future Plans Revealed!
Mon, Aug 21, 2023
Mon, Aug 21, 2023
By accepting cookies, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts.